HealthEquity, Inc.HQYNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank15
3Y CAGR-25.1%
5Y CAGR-30.9%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-25.1%/yr
vs -4.9%/yr prior
5Y CAGR
-30.9%/yr
Recent acceleration
Acceleration
-20.2pp
Decelerating
Percentile
P15
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthDecelerating
| Period | Value |
|---|---|
| 2026 | 9.60% |
| 2025 | 9.46% |
| 2024 | 13.15% |
| 2023 | 22.88% |
| 2022 | 26.08% |
| 2021 | 60.89% |
| 2020 | 121.29% |
| 2019 | 28.02% |
| 2018 | 22.39% |
| 2017 | 32.93% |